Cite
APA Citation
Ogawa, E., Nomura, H., Nakamuta, M., Furusyo, N., Koyanagi, T., Dohmen, K., Ooho, A., Satoh, T., Kawano, A., Kajiwara, E., Takahashi, K., Azuma, K., Kato, M., Shimoda, S., Hayashi, J., & , (2020). tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B. Liver international, 40, 1578–1589. http://access.bl.uk/ark:/81055/vdc_100103765094.0x00000e